ACT-based nursing intervention
OtherACT-based nursing intervention is a 1:1 single online session with a nurse, which takes about 60 minutes followed by a daily self-monitoring survey for one week, which encourages patients to practice ACT.
NCT Number: NCT06813001
The purpose of this study is to evaluate the feasiblity and effectiveness of an Acceptance and Commitment Therapy (ACT)-based nursing intervention aimed at managing psychological flexibility, distress, anxiety, depression, fear of cancer recurrence/progression, quality of life, and symptoms. Patients will participate in a single online session with a nurse, followed by a daily self-monitoring survey online for one week. Data will be collected at baseline (prior to the ACT session), on day 8 (after one week of self-monitoring), and at 5 weeks. Primary outcome is psychological flexibility.
Trial opening soon.
Get Notified19 year–75 year
Female
Interventional
Not applicable
This study is a preliminary single-group pre-post design aimed at developing and evaluating the feasibility of an ACT-based nursing intervention for distress management in patients with ovarian cancer. A total of 25 ovarian cancer patients who consent to participate will be enrolled in the study. Paticipants will receive a one-time ACT-based nursing intervention lasting approximately 60 minutes.
The researcher will coordinate schedules with participants to deliver the ACT-based nursing intervention using Zoom, a video conferencing platform which minimizes time and location constraints. Before the intervention, the research will ensure that the participants' video conferencing is working properly to minimize potential difficulties during the session.
Following the single-session intervention, the researcher will send a daily Google Form link to participants for seven consecutive days. Participants will be encouraged to access the link and complete self-monitoring surveys to reinforce the key components addressed in the program.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
ACT-based nursing intervention is a 1:1 single online session with a nurse, which takes about 60 minutes followed by a daily self-monitoring survey for one week, which encourages patients to practice ACT.
Time frame: Psychological distress will be assessed at baseline and on the last day of self-monitoring (Day 8).
Psychological distress measured by Distress Thermometer.
Time frame: within 3 weeks after the last day of self-monitoring (window: 7 days)
depression measured by the Hospital Anxiety and Depression Scale (HADS).
Time frame: within 3 weeks after the last day of self-monitoring (window: 7 days)
Anxiety by the Hospital Anxiety and Depression Scale (HADS).
Time frame: within 3 weeks after the last day of self-monitoring (window: 7 days)
Fear of cancer recurrence measured by the Fear of Cancer Recurrence Index (FCRI).
Time frame: within 3 weeks after the last day of self-monitoring (window: 7 days)
Psychological flexibility measured by the Acceptance and Action Questionnaire-II (AAQ-II).
Time frame: within 3 weeks after the last day of self-monitoring (window: 7 days)
Quality of life measured by the ECORTC QLQ C-30.
Time frame: within 3 weeks after the last day of self-monitoring (window: 7 days)
Symptoms measured by the EORTC QLQ-OV28.
Contact information is provided by the study sponsor or research team.
Yonsei University
Other
Development of ACT (Acceptance and Commitment Therapy)-Based Nurse-led Intervention for Ovarian Cancer Patients
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07690332
Adnexal Diseases, Endocrine Gland Neoplasms
View Trial DetailsNCT07724106
Adnexal Diseases, Endocrine Gland Neoplasms
View Trial DetailsNCT07718854
Adenocarcinoma, Adenocarcinoma, Clear Cell
Boston, Massachusetts, United States
View Trial DetailsNCT07720180
Adnexal Diseases, Endocrine Gland Neoplasms
Charleston, South Carolina, United States
View Trial Details